Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Issuance( Retirement)of Debt Net | -4.24 | -5.34 | 1.42 | 8.16 |
Net Changein Cash | 0.09 | -0.03 | -2.94 | 3.06 |
Cash Taxes Paid | 0.04 | 0.16 | 0.67 | 0.37 |
Net Income/ Starting Line | 0.13 | 0.61 | 2.28 | 1.46 |
Changesin Working Capital | -14.80 | 4.70 | -6.64 | -27.89 |
Cashfrom Operating Activities | -14.62 | 5.32 | -4.35 | -26.43 |
Cash Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 |
Cashfrom Financing Activities | 14.97 | -5.34 | 1.42 | 29.49 |
Issuance( Retirement)of Stock Net | 19.21 | 0.00 | 0.00 | 21.33 |
Depreciation/ Depletion | 0.05 | 0.01 | 0.00 | 0.00 |
Other Investing Cash Flow Items Total | 0.00 | - | 0.00 | 0.00 |
Capital Expenditures | -0.26 | -0.01 | -0.01 | 0.00 |
period Type | - | - | - | - |
Financing Cash Flow Items | 0.00 | 0.00 | 0.00 | 0.00 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Cashfrom Investing Activities | -0.26 | -0.01 | -0.01 | 0.00 |
Non- Cash Items | - | - | 0.00 | 0.00 |
Deferred Taxes | - | - | 0.00 | 0.00 |
Evoq Remedies Dividend Evoq Remedies Bonus Evoq Remedies News Evoq Remedies AGM Evoq Remedies Rights Evoq Remedies Splits Evoq Remedies Board Meetings Evoq Remedies Key Metrics Evoq Remedies Shareholdings Evoq Remedies Profit Loss Evoq Remedies Balance Sheet Evoq Remedies Q1 Results Evoq Remedies Q2 Results Evoq Remedies Q3 Results Evoq Remedies Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks